Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review

Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure

(2017) Adam J. DiPippo et al.   JOURNAL OF INFECTION

Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

(2016) Bhavarth S. Shukla et al.   CLINICAL INFECTIOUS DISEASES

Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line–Associated Bloodstream Infections From Oncology Settings, 2009–2012

(2016) Isaac See et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose

(2016) Y.-C. Chuang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L

(2016) Pearlie P. Chong et al.   CLINICAL THERAPEUTICS

Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis

(2016) Hsiu-Yin Chiang et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis

(2016) Ming Zhao et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci

(2016) William R. Miller et al.   Cold Spring Harbor Perspectives in Medicine

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

(2015) Sujata M. Bhavnani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience

(2015) James A. McKinnell et al.   CLINICAL INFECTIOUS DISEASES

Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients

(2015) Nicholas S. Britt et al.   CLINICAL INFECTIOUS DISEASES

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia

(2015) Pamela A. Moise et al.   CLINICAL THERAPEUTICS

Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy

(2015) Heinrich Lellek et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009–2013)

(2015) Helio S. Sader et al.   Journal of Global Antimicrobial Resistance

Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci

(2014) Kayoko Hayakawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis

(2014) B. J. Werth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Musculoskeletal Safety Outcomes of Patients Receiving Daptomycin with HMG-CoA Reductase Inhibitors

(2014) Christopher M. Bland et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis

(2014) Yu-Chung Chuang et al.   BMC INFECTIOUS DISEASES

Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci

(2014) Jose M. Munita et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia

(2013) Eleni P. Balli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections

(2013) Donald W. Whang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections

(2013) Anthony M. Casapao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

(2013) J Casey et al.   BONE MARROW TRANSPLANTATION

Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and Experience

(2013) Shruta Rege et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations

(2012) Ashley D. Hall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?

(2011) E. A. King et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

(2010) Sujata M. Bhavnani et al.   CLINICAL INFECTIOUS DISEASES

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

(2010) Christopher W. Crank et al.   CLINICAL THERAPEUTICS

Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients

(2009) Jason C Gallagher et al.   PHARMACOTHERAPY

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES